How to Do Allergen Risk Assessment (VITAL) | GIFSQ

How to Do Allergen Risk Assessment with VITAL: A Step-by-Step Guide

Precautionary allergen labeling — “may contain” — is overused. Applied defensively where no real risk exists, it restricts allergic consumers unnecessarily and erodes the trust the warning needs where the risk is real. VITAL (Voluntary Incidental Trace Allergen Labelling), the quantitative risk assessment framework from the Allergen Bureau, replaces guesswork with science: estimating the actual allergen exposure from cross-contact and comparing it against reference doses. This guide shows how to apply VITAL rigorously.

Step 1: Understand the VITAL framework

VITAL rests on a few core concepts. Reference doses are the amounts of each allergen’s protein — derived from clinical dose-distribution data — below which the vast majority of allergic consumers would not react. Action levels are concentration thresholds derived from those reference doses and the product’s serving size; they drive the labeling decision. Action Level 1 (exposure below the reference dose) means no PAL is needed. Action Level 2 (exposure above it) means PAL is warranted.

The framework is voluntary but widely recognized as the industry standard for science-based PAL decisions. Its purpose is informed, consistent labeling — quantitative assessment instead of precaution-by-default. Understand these concepts properly before applying them; misapplied VITAL is worse than no VITAL, because it wears the authority of science.

Step 2: Map the cross-contact routes

For each product and line, map every route by which the allergen could reach the product unintentionally: residual on shared equipment after changeover, airborne dust from powders, transfer by people and their tools, carryover through rework, and cross-contact already present in incoming ingredients from suppliers.

Map specifically — per product, per line — and quantify where possible. These routes and their estimated magnitudes are VITAL’s input; a route you never mapped cannot be assessed, and the assessment is only as complete as the map.

Step 3: Estimate the exposure

Quantify the dose. Estimate the allergen concentration in the product — from cleaning validation residual data, product testing, or calculation, measured data preferred over assumed. Take the realistic serving size: the amount consumed per eating occasion. Multiply concentration by serving to get the dose in milligrams of allergen protein — the number VITAL compares against the reference dose.

Handle the uncertainty explicitly: state the assumptions, keep the conservatism reasonable and protective without becoming absurd, and document all of it. The dose estimate is the comparison point for the entire decision, so estimate it scientifically and defensibly.

Step 4: Gather the evidence base

An assessment is only as good as its inputs. Pull the cleaning validation data for the residual levels, the product testing results where allergen was quantified, the supplier data on cross-contact in incoming materials, realistic consumption and serving-size data, and the current literature values for the reference doses. Assess the quality of each input — reliable data versus rough estimates — because garbage in means garbage out.

Where the data matters most, measure rather than assume. Commission the testing, run the validation, get the supplier numbers. The evidence base is the foundation; build it properly.

Step 5: Compare the dose against the reference dose

Take the estimated dose and compare it against the current VITAL reference dose for that allergen. Below the reference dose: Action Level 1, no PAL, decided with confidence. Above it: Action Level 2, PAL warranted — the “may contain [allergen]” stated honestly and specifically.

Document the calculation, the assumptions, and the decision. Schedule the review. The science makes the decision here, not the fear of liability and not the marketing preference. Below means no PAL with confidence; above means PAL with honesty.

Step 6: Manage the uncertainty like a scientist

Every assessment has unknowns. Make the assumptions explicit and documented rather than buried. Keep the conservatism protective but reasonable — assumptions so absurd they guarantee Action Level 2 are not conservative, they are dishonest. Test the sensitivity of the key variables: which inputs actually move the decision? Acknowledge the data gaps, prioritize filling the ones that matter, and revisit the assumptions at review.

Uncertainty is managed, not ignored and not inflated. An assessment whose assumptions are documented honestly is credible; one that hides them is not.

Step 7: Document the VITAL file

The assessment file must be reproducible: the scope (which product, which line), the mapped routes, the data inputs with their sources, the dose calculations shown in full, the reference dose applied and its version, the PAL decision with its rationale, the explicit assumptions, the scheduled review date, and the authorized approval.

Write it so an auditor or regulator can follow the science from evidence to decision. Document the science reproducibly — that is what makes the file defensible.

Step 8: Make the labeling decisions honestly

Apply the outcomes consistently across products. Action Level 1: no PAL, confidently, with the decision documented. Action Level 2: PAL, specific — “may contain [allergen]” — honest about the assessed risk. Record the rationale internally so the decision is traceable, apply the same logic across the product range, and revisit the decisions when the data updates.

PAL becomes what it should be: informed, not defensive, and not absent where it is needed. The allergic consumer deserves the truth, not the legal shield.

Step 9: Verify the assessment against reality

Close the loop. Test product periodically to confirm the assessed picture still holds. Confirm the cleaning validation is maintained. Keep assuring the suppliers on an ongoing basis. Review incidents for anything that contradicts the assessment and update it. Trend the data and read the program’s health in it.

Verification checks the assessment’s predictions against reality. An assessment that is never verified is a hypothesis filed away; a living one is confirmed, corrected, and sustained.

Step 10: Keep the assessment alive

Maintain it on a defined schedule and on triggers: new products, supplier changes, incidents, process changes — each gets the assessment reassessed. Update the reference doses as the science develops and apply the new values; a decision made on superseded reference doses is a decision on outdated science. Keep improving the data, refining the estimates, and control the documentation by version.

The assessment is current or it is nothing. Review is the discipline that keeps it alive.

Working principles

Quantify, don’t guess. Reference doses, exposure estimates, action levels — the science replaces the defensive “may contain everything” and the hopeful “it’s probably fine” alike.

Data drives decisions. Cleaning validation, product testing, supplier data — the evidence base determines the outcome. Measure where it matters and let the numbers speak.

Label honestly. Action Level 1 means no PAL, stated with confidence. Action Level 2 means PAL, stated specifically. The allergic consumer’s trust is built on the truth of these decisions.

How it goes wrong in practice

The defensive PAL is the starting point for many companies: “may contain” on everything, on legal advice, with no assessment behind any of it. Allergic consumers get the choice denied across the range and the trust erodes. Then VITAL gets implemented properly — assessments run, PALs removed where unwarranted and retained where needed — and the honest warnings become trusted. The defensive posture was the lazy one; the science is better, and the brand earns respect for it.

The unassessed changeover is the quantification surprise: a shared line with an allergen changeover “cleaned” but never quantified. VITAL gets applied — the residual measured, the dose calculated — and the result lands at Action Level 2. The PAL goes on, the label becomes honest, and the consumer is protected. The quantification revealed what the assumption had hidden.

The outdated reference is the maintenance failure: an assessment built on superseded reference doses, the science since updated. When someone finally applies the current values, the decisions change for two products. The lesson is procedural: reference doses are living science, and the assessment’s maintenance must include tracking them.

The supplier dose is the corrected assumption: a supplier’s cross-contact described as “low” and assumed negligible. Testing gets commissioned, the dose comes back higher than assumed, and the PAL is warranted after all. The assumption is corrected by data. Verify suppliers quantitatively; trust, measured.

Common mistakes

Running the numbers to justify a pre-made decision. The team wants no PAL (or wants the legal cover of one) and tunes the assumptions until the calculation agrees. That is not risk assessment; it is arithmetic in service of a preference. Let the data and the reference doses decide, and document the assumptions honestly.

Using outdated reference doses. The assessment was built years ago and nobody tracked the science since. Reference doses get updated as clinical data grows; decisions resting on superseded values are decisions on outdated science. Track the current VITAL values and reassess when they change.

Assessing with assumed instead of measured data. Every input is an estimate stacked on an estimate — assumed residuals, assumed transfer, assumed serving sizes. Where the decision is close or the risk is high, measure: validate the cleaning, test the product, get the supplier numbers. Garbage in, garbage out.

Forgetting the serving size reality. The calculation uses the label serving while consumers eat three times that amount, or uses an unrealistic “per 100 g” figure. Use realistic consumption per eating occasion. The dose depends on it directly.

Treating the assessment as one-and-done. The VITAL file gets completed, filed, and never reviewed while products, suppliers, and processes change around it. Schedule the review, define the triggers, and keep it living. A stale assessment is a false foundation.

Applying VITAL without understanding it. The tool gets used as a black box — numbers in, action level out — by people who cannot explain a reference dose. Misapplied VITAL wears science’s authority while producing nonsense. Train the assessors in the framework before letting them use it.

Checklist — allergen risk assessment with VITAL

• [ ] VITAL understood — reference doses, action levels, and purpose grasped; framework applied correctly, not as a black box
• [ ] Cross-contact mapped — routes identified per product and line; quantified where possible
• [ ] Exposure estimated — concentration, realistic serving, dose in mg protein; uncertainty and assumptions documented
• [ ] Evidence gathered — cleaning validation, product testing, supplier data, consumption data; input quality assessed
• [ ] Reference doses applied — current VITAL values; dose compared; action level determined and documented
• [ ] Uncertainty managed — assumptions explicit; conservatism reasonable; sensitivities tested; gaps prioritized
• [ ] Assessment documented — scope through approval; reproducible; review date scheduled; version controlled
• [ ] PAL decided honestly — Action Level 1/2 applied consistently; rationale recorded; decisions revisited on new data
• [ ] Assessment verified — product testing confirms; cleaning maintained; suppliers assured; incidents feed back
• [ ] Assessment living — scheduled reviews; change triggers defined; science tracked and applied